Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 01/22/2013 9:13:30 PM
Post# of 72447
Posted By: petemantx

Since we were told by LE that Prurisol trial in Europe would start around the very end of March, how much further word can we get of any significance?  I think the next major news re: Prurisol will be possibly mid April or possibly as late as early May when the entire 30 days of dosing are completed.  I can live with that as it is only 14 weeks or so and within a few weeks later Prurisol will be a done deal as to whether it is a bang or a bust; strongly expecting the bang!


The Kevetrin trial IMO may be among the top 2 or 3 trials ever conducted (possibly #1) and if D-F wants to go extremely slow in handing out info to be rock sure they have sufficient data that is incontestable as to how effective Kevetrin is, then I can also understand that.  Am prepared for data as late as end of May at the ASCO mtg.  Would love to get some word in the next 6 weeks that biomarkers are appearing but that may or may not come to pass.


Best news for Jan/Feb may just be that CTIX is finally getting some publicity in various venues and more and more eyes are being paid to it partly due to the fine work of our fellow IH posters.


Just happy as each day passes without any negative trials report














(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site